Home Nomic

Nomic

In operation
Series B
Proteomics Technology Platform Developer
Basic
Enterprise Profile

Basic Information

Nomic (formerly nplex biosciences) has developed a proteomics technology platform aimed at understanding, detecting, and treating diseases using DNA nanotechnology. We are building nELISA, a next-generation ELISA platform for large-scale and high-throughput protein measurement. nELISA is designed to integrate seamlessly into current biological workflows and is uniquely suited for various use cases in drug and biomarker development workflows.
Nomic Bio
Montreal,Quebec,Canada
less than 15 people
January 01, 2017
hello@nomic.bio

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Scientific Research and Experimental Development Services # Diagnostic Manufacturing
Technology
Protein Technology
Concept
Disease Diagnosis
Application Scenarios
Nanotechnology